(Q53149258)

11 May 2018

title

Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation. (English)

1 reference

11 May 2018

author

Mieke Van Hemelrijck

1

1 reference

11 May 2018

Hans Garmo

4

1 reference

11 May 2018

Adrian Hayday

6

1 reference

11 May 2018

Mats Lambe

7

1 reference

11 May 2018

Lars Holmberg

8

object named as

Lars Holmberg

1 reference

11 May 2018

3

Göran Walldius

1 reference

11 May 2018

Ingmar Jungner

2

object named as

Ingmar Jungner

1 reference

11 May 2018

Elisa Binda

5

object named as

Elisa Binda

1 reference

11 May 2018

author name string

Niklas Hammar

9

1 reference

11 May 2018

language of work or name

English

0 references

publication date

12 January 2011

1 reference

11 May 2018

International Journal of Cancer

published in

1 reference

11 May 2018

volume

129

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

1485-1492

1 reference

11 May 2018

Inflammation in prostate carcinogenesis

cites work

1 reference

Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study

21 January 2018

1 reference

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial

21 January 2018

1 reference

A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk

21 January 2018

1 reference

Inflammation and metabolic disorders.

21 January 2018

1 reference

A systematic review of the association between circulating concentrations of C reactive protein and cancer

21 January 2018

1 reference

Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality

21 January 2018

1 reference

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

21 January 2018

1 reference

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

21 January 2018

1 reference

No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer

21 January 2018

1 reference

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).

21 January 2018

1 reference

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS).

21 January 2018

1 reference

Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study

21 January 2018

1 reference

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females

21 January 2018

1 reference

A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.

21 January 2018

1 reference

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study

21 January 2018

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer

21 January 2018

1 reference

Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages

21 January 2018

1 reference

CXC receptor-1 silencing inhibits androgen-independent prostate cancer

21 January 2018

1 reference

Plasma C-reactive protein and risk of cancer: a prospective study from Greece.

21 January 2018

1 reference

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

21 January 2018

1 reference

Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma

21 January 2018

1 reference

Systemic inflammation, nutritional status and survival in patients with cancer.

21 January 2018

1 reference

Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study

21 January 2018

1 reference

Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.

21 January 2018

1 reference

Relationships among obesity, inflammation, and insulin resistance in african americans and west africans

21 January 2018

1 reference

Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness

21 January 2018

1 reference

Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?

21 January 2018

1 reference

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25773

1 reference

11 May 2018

1 reference

11 May 2018